Photo via Fox News

Trump CMS faces bipartisan pushback over Medicare proposal tied to Biden-era drug pricing law

Read the original at Fox News ↗
Cite

Compton, S. (2026, September 29). Trump CMS faces bipartisan pushback over Medicare proposal tied to Biden-era drug pricing law. Fox News. https://www.foxnews.com/politics/trump-cms-faces-bipartisan-pushback-over-medicare-proposal-tied-biden-era-drug-pricing-law

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

Fox News · collected 2026-09-29 · by Sophia Compton

Quick Summary

More than 50 bipartisan lawmakers are urging the Trump administration's Centers for Medicare & Medicaid Services (CMS) to remove a proposed policy regarding fixed-dose combination drugs from its final rule implementing Medicare’s Drug Price Negotiation Program. Signed into law in 2022 under President Biden, this program aims to negotiate drug prices. The lawmakers argue that the proposal could hasten price negotiations for improved versions of existing medications, potentially discouraging pharmaceutical companies from developing these advancements and impacting patient access, especially in rural areas.
Written by AI on 2026-09-29, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

A bipartisan group of over 50 lawmakers is urging the Trump administration's Centers for Medicare & Medicaid Services (CMS) Administrator, Dr. Mehmet Oz, not to finalize a proposed Medicare policy tied to the Biden-era Inflation Reduction Act. The lawmakers submitted an official letter on September 21, arguing that the policy could discourage the development of improved cancer treatments. Specifically, they are concerned about CMS's proposal for fixed-dose combination policies under Medicare’s Drug Price Negotiation Program, which was established by the Inflation Reduction Act in 2022. The lawmakers claim this proposal would cause newer versions of existing drugs to face Medicare price negotiations sooner after FDA approval, potentially reducing drugmakers' incentives to create better treatments.

Written for “Medicare Drug Pricing Law” on 2026-11-03, grounded in this article and the 0 other(s) covering the same event.

Story

📰 Medicare Drug Pricing Law
Politics · 1 article(s) covering the same event.

Compared with similar articles

This article reads unscored and hedges 11% of its claims. Each row says how that neighbour differs.
Washington Examiner
Hedges 0 of 26 claims Outlet record 70/100
“The articles discuss different aspects of Medicare policy changes and do not refer to the same specific incident or time frame.”
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
18
sentences that state something as happening or true
Uncertain
11%
2 of 18 hedged ("reportedly", "may", "according to")
Leaning
withheld
no quote in the article backed the model's score
Publisher signals
69/100
Fox News's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Politics
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-09-29 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Fox News · 6363 article(s) · 11 correction(s) detected
Running correction rate · 11 correction(s)

Who wrote this

Sophia Compton
11 article(s) here · 1 carrying a prediction
🔮 We ask anyone who may have information, regardless of how insignificant it may seem, to come forward and assist with this investigation." California State Parks Police closed Jetty Road and Moss Landing State Beach at the request of the sheriff's office as the investigation continued. "
🔮 "This is an active investigation, and no further information will be released at this time."
🔮 Republican Michigan Senate candidate Mike Rogers took aim at Democratic opponent Abdul El-Sayed during a town hall with Fox News host Sean Hannity on Monday, warning voters that his rival's policies would hurt the state.
🔮 BIBI NETANYAHU WILL NEVER LET YOU DOWN!" Trump said.
🔮 Mark Lopez-Trigo, a Florida personal injury attorney and founding partner of Padron & Lopez-Trigo, told Fox News Digital that investigators will likely examine whether the incident was isolated or points to an issue with the ride's safety equipment, maintenance or inspections.
🔮 The confirmed death toll includes only victims buried by authorities in Djibouti and could rise as additional bodies are verified, IOM Chief of Mission in Djibouti Alexandre Coissac told The Associated Press.
🔮 CBS Pittsburgh reported that Stone was four days away from giving birth, while a family friend told Erie News Now she was expected to deliver "in a couple of days." A GoFundMe organized to help with funeral expenses identified Stone's children as Isiah and Amari’anna and her unborn baby as Kyrie.
🔮 A bipartisan group of more than 50 lawmakers is urging the Trump administration not to finalize a proposed Medicare policy tied to the Biden-era drug price negotiation program, arguing it could discourage development of improved cancer treatments.
🔮 The Harris County Sheriff's Office could not immediately be reached by Fox News Digital for comment.
🔮 Chiu also said Trump owns roughly 41% of Trump Media and "is personally benefiting from this business scheme." A Trump Media spokesperson pushed back on the allegations, telling Fox News Digital, "The people of California should outsource their future lawsuits to AI chatbots who, unlike the left-wing activists masquerading as attorneys who filed this lawsuit, will grasp the basic distinction between public and nonpublic information.
Also by Sophia Compton
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 11 articles by Sophia Compton →

Topics

CMS FDA Fox News Digital Medicare the Trump administration

Subjects

CMS ORG · 7× Medicare ORG · 6× FDA ORG · 2× Fox News Digital ORG · 2× N.C. GPE · 2× Biden PERSON · 1× Centers for Medicare & Medicaid Services ORG · 1× Mehmet Oz PERSON · 1× The Medicare Drug Price Negotiation Program ORG · 1× the Trump administration ORG · 1×

Narrative

In a Sept. 21 letter obtained by Fox News Digital, the lawmakers called on Centers for Medicare & Medicaid Services (CMS) Administrator Dr. Mehmet Oz to remove the agency's proposed fixed-dose combination policy from its final rule implementing Medicare's Drug Price Negotiation Program.
framing: assertive · carried by 1 article(s) · first seen 2026-09-29
🔮 A bipartisan group of more than 50 lawmakers is urging the Trump administration not to finalize a proposed Medicare policy tied to the Biden-era drug price negotiation program, arguing it could discourage development of improved cancer treatments.

Claims (18 extracted, 2 hedged)

A bipartisan group of more than 50 lawmakers is urging the Trump administration not to finalize a proposed Medicare policy tied to the Biden-era drug price negotiation program, arguing it could discourage development of improved cancer treatments. uncertain
it → urge → treatments
In a Sept. 21 letter obtained by Fox News Digital, the lawmakers called on Centers for Medicare & Medicaid Services (CMS) Administrator Dr. Mehmet Oz to remove the agency's proposed fixed-dose combination policy from its final rule implementing Medicare's Drug Price Negotiation Program. asserted
lawmakers → obtain → Program
The Medicare Drug Price Negotiation Program was created under the Inflation Reduction Act, which former President Joe Biden signed into law in 2022. asserted
Biden → create → 2022
The Trump administration proposed the policy in June as part of implementing that program. asserted
administration → propose → program
At the center of the dispute is how Medicare would treat newer versions of existing drugs for price negotiation purposes. asserted
treat → treat → purposes
The lawmakers argue the proposal would cause some improved treatments to face Medicare price negotiations much sooner after receiving Food and Drug Administration (FDA) approval. asserted
treatments → argue → approval
They say that would reduce incentives for drugmakers to develop better versions of existing medicines. asserted
drugmakers → say → medicines
"If finalized, the proposed fixed-dose combination policy would subject these advancements to negotiation almost immediately after FDA approval, harming patient access as well as incentives to develop these improved therapies," the lawmakers wrote. asserted
lawmakers → finalize → therapies
CMS, meanwhile, said the proposal is designed to prevent drugmakers from avoiding or delaying negotiated Medicare prices by making only limited changes to existing drugs and introducing them as new products. asserted
proposal → say → products
The lawmakers pointed to advances in cancer immunotherapy that allow some patients to receive a quick injection instead of spending hours receiving an intravenous infusion. asserted
patients → point → infusion
They said those improvements can make treatment faster, easier and more accessible, particularly for patients in rural areas. asserted
treatment → say → areas
"Patients fighting cancer deserve access to the most advanced new therapies, and if CMS finalizes this proposal, those advances are less likely to reach those who need it the most," the letter states. asserted
letter → fight → it
The lawmakers also argued the FDA already evaluates the therapies as separate medicines, requiring separate clinical trials and approvals. asserted
FDA → argue → trials
They said CMS should treat those therapies as separate medicines under the Medicare drug price negotiation program. asserted
CMS → say → program
The lawmakers also argued that CMS actuaries "have not been able to show this policy would produce meaningful savings for taxpayers." "We strongly urge CMS to withdraw the fixed-dose combination proposal from the final rule," the letter states. asserted
letter → argue → rule
The patients we represent need policies that expand access to lifesaving care and reward medical progress and innovation in the treatment of deadly diseases." asserted
that → represent → diseases
The letter was signed by more than 50 lawmakers from both parties, including Reps. John Joyce, R-Pa., Darin LaHood, R-Ill., Mike Kennedy, R-Utah, Tim Moore, R-N.C., Jim Costa, D-Calif., Donald Davis, D-N.C., and more. asserted
letter → sign → Joyce
CMS could not immediately be reached by Fox News Digital for comment. uncertain
CMS → reach → comment
💬Give feedback
🕘History 🎫Support